BILLY CHANCELLOR: Open Payments
NPI 1053328385 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 81 payments from 9 companies in 2025. Trend: 2023 $1,329 · 2024 $3,856 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 58 | $401 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| SCPHARMACEUTICALS INC. | 1 | $41 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: SAPIEN 3 Ultra RESILIA, LEQVIO, LifeVest, Kerendia, FUROSCIX, CAMZYOS, Assure WCD, AMVUTTRA.
Industry payments across MS — which companies pay providers there.
